Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT02217228. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Prospective, Multicenter, Controlled Study With Blinded Assessment to Determine the Safety and Effectiveness of the Sebacia Acne Treatment System in the Treatment of Inflammatory Acne Vulgaris
Study identification
- NCT ID
- NCT02217228
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Sebacia, Inc.
- Industry
- Enrollment
- 394 participants
Conditions and interventions
Conditions
Interventions
- Sebacia microparticles and laser Device
- Vehicle suspension and laser Device
- Sebacia microparticles without laser Device
Device
Eligibility (public fields only)
- Age range
- 15 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2014
- Primary completion
- Nov 30, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Sep 17, 2017
2014 – 2015
United States locations
- U.S. sites
- 19
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clear Dermatology & Aesthetics Center | Scottsdale | Arizona | 85255 | — |
| Laser & Skin Surgery Center of Northern California | Sacramento | California | 95816 | — |
| Center for Dermatology & Laser Surgery | Sacramento | California | 95819 | — |
| Miami Dermatology & Laser Institute | Miami | Florida | 33173 | — |
| Spencer Dermatology | St. Petersburg | Florida | 33716 | — |
| Gwinnett Dermatology, PC | Snellville | Georgia | 30078 | — |
| The Dermatology Institute-DuPage Medical Group | Naperville | Illinois | 60563 | — |
| Shideler Clinical Research Center | Carmel | Indiana | 46032 | — |
| Maryland Laser, Skin & Vein Institute | Hunt Valley | Maryland | 21030 | — |
| Clarkston Skin Research | Clarkston | Michigan | 48346 | — |
| James Q Del Rosso, DO, LLC | Las Vegas | Nevada | 89144 | — |
| Skin Laser & Surgery Specialists of NY & NJ | Hackensack | New Jersey | 07601 | — |
| Dermatology, Laser & Vein Specialists of the Carolinas | Charlotte | North Carolina | 28207 | — |
| Penn State Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Yardley Dermatology Associates | Yardley | Pennsylvania | 19067 | — |
| Dermatology & Laser Center of Charleston | Charleston | South Carolina | 29414 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| Spokane Dermatology Clinic | Spokane | Washington | 92204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02217228, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 17, 2017 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02217228 live on ClinicalTrials.gov.